Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability Data

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going clinical Phase I trial with the 4-1BB (CD137) drug...

Related Keywords

Sweden ,Julie Silber ,Aptevo Therapeutics Inc ,Shanghai Henlius Biotech Inc ,Macrogenics Inc ,Orion Corporation ,Biotheus Inc ,Nasdaq Stockholm ,Shanghai Henlius Biotech ,Alligator Bioscience ,Press Release ,